Clinical Trials Browser

Phase 4 × Interventional × Neutropenia × Clear all

Neoplasms, Neutropenia

NCT05926063 2024-03-08

SAFE

Phase 4 Recruiting

410 enrolled

Classical hematologyOther hematologic neoplasm

Infections, Leukemia, Neutropenia, Febrile Neutropenia

NCT04009941 2020-10-28

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Phase 4 Completed

104 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT04187755 2019-12-06

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Phase 4 Completed

72 enrolled

Classical hematologyOther hematologic neoplasm

Fever, Leukemia, Neoplasms, Neutropenia, Febrile Neutropenia

NCT02149329 2019-09-25

SHORT

Phase 4 Completed

276 enrolled

Classical hematologyOther hematologic neoplasm

Fever, Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT01271582 2019-01-29

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Phase 4 Unknown

1,500 enrolled

Gastrointestinal

Neutropenia, Stomach Neoplasms, Colorectal Neoplasms

NCT00686543 2017-04-07

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Phase 4 Completed

75 enrolled 14 charts

Other hematologic neoplasm

Mycoses, Neutropenia, Leukemia, Myeloid, Acute

NCT02996617 2016-12-19

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

Phase 4 Unknown

240 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neutropenia, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT02967341 2016-11-18

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Phase 4 Unknown

15 enrolled

Neoplasms, Neutropenia

NCT00030758 2013-08-07

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Phase 4 Unknown

816 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT01571518 2012-04-05

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

Phase 4 Unknown

60 enrolled

Neutropenia

NCT00257790 2011-07-06

The Tobramycin Study

Phase 4 Completed

210 enrolled

Fever, Neoplasms, Neutropenia

NCT00125723 2010-12-23

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

Phase 4 Completed

2,252 enrolled

Neoplasms, Neutropenia

NCT00277160 2010-10-08

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Phase 4 Completed

852 enrolled

BreastGynecologicLymphoidThoracic

Breast Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neutropenia, Ovarian Neoplasms

NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Phase 4 Completed

Thoracic

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia

NCT00454272 2009-03-06

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

Phase 4 Completed

197 enrolled

Classical hematology

Fever, Infections, Neoplasms, Neutropenia, Febrile Neutropenia

Clinical Trials

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

SAFE

Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

SHORT

Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer

Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

The Tobramycin Study

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients